The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Expert Highlights Areas of Research in MCL

Krish Patel, MD
Published Online:5:08 PM, Mon February 11, 2019


Krish Patel, MD, an oncologist at the Swedish Cancer Institute, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma (MCL).

Moving forward, Patel thinks it will be interesting to see how CAR T-cell therapy evolves in this space. This is an exciting area of research for MCL, as well as the other lymphoid malignancies where these agents are also being investigated. However, it is too early to know the ultimate impact of this research.

Additionally, Patel suggests watching the readouts for combination studies involving BCL-2 inhibitors as treatment for patients with MCL.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.